Birmingham City University welcomed leading figures in the life sciences sector from across the region to its campus last week.
Posted 29 November 2021
Representatives from the life sciences industry network Medilink Midlands held their first in-person AGM since the outbreak of the COVID-19 pandemic – at the University’s Seacole Building at its City South Campus in Edgbaston, Birmingham on Tuesday 16 November.
As home to the University’s health and life sciences courses, the Seacole Building was a fitting environment for the Medilink Midlands meeting. Subjects taught on site include biomedical sciences, and medical engineering applications for healthcare. Genetics and bone mineral density, and the biomarkers of chronic obstructive pulmonary disease (COPD) are among the topics currently being researched at the centre.
The £30 million Seacole Building also houses state-of-the-art teaching facilities including a simulated operating theatre and hospital wards, a fully-equipped birthing room, a simulated home environment and a fully-functional radiography suite and 3D imaging diagnostic suite.
Medilink Midlands representative were taken on a tour of the facilities as part of their visit and also met with members of the University’s Higher Level Skills Match project team. Part-funded by the European Social Fund, the project provides SMEs with free, account managed recruitment support for graduate level roles as well as fully-funded workshops based on live business development trends.
Professor Martin Levermore, Chair of Medilink Midlands, and also a Visiting Professor at Birmingham City University, said:
"We were immensely grateful to Birmingham City University for hosting us and for providing us with a tour of their excellent teaching and learning facilities.
Hannah Abbott, Head of School of Health Sciences at Birmingham City University, said:
“We were delighted to welcome Medilink Midlands to our campus last week. It’s vitally important that we develop and maintain links with such well-connected professional membership bodies to ensure that our teaching and learning, and our research outputs, are up to date with the modern demands of the health and life sciences sector.”
